Iguratimod
-
Iguratimod
structure -
-
CAS No:
123663-49-0
-
Formula:
C17H14N2O6S
-
Chemical Name:
Iguratimod
-
Synonyms:
Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide;T 614;3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one;Iguratimod;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-chromen-7-yl]methanesulfonamide;T 614 (antiinflammatory);Careram;Kolbet
- Categories:
-
CAS No:
Description
In August 2011, China’s State FDA approved Simcere Pharmaceutical Group’s new drug application for iguratimod (T-614), a disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Preclinical in vivo studies indicated that iguratimod was effective in an established adjuvant-induced arthritis model (ED40=3.6 mg/kg) in rats and also efficacious in a type II collagen-induced arthritis model in DBA/1J mice at 30 mg and 100 mg/kg.
Iguratimod is an organic molecular entity.|Iguratimod is under investigation in Rheumatoid Arthritis.
Characteristics
119
1.4
1.52±0.1 g/cm3(Predicted)
238.0 to 242.0 °C
580.6±60.0 °C(Predicted)
304.9±32.9 °C
1.674
Safety Information
P201, P202, P281, P308+P313, P405, P501
H361
|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Iguratimod Use and Manufacturing
Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.
Computed Properties
Molecular Weight:374.4
XLogP3:1.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:5
Exact Mass:374.05725734
Monoisotopic Mass:374.05725734
Topological Polar Surface Area:119
Heavy Atom Count:26
Complexity:665
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It can inhibit foot swelling in collagen arthritis model rats and alleviate the destruction of rat bone and cartilage tissue; it can inhibit the activity of nuclear factor-κB (NF-κB) in vitro, thereby inhibiting the production of inflammatory cytokines; it can directly interact with mouse and human B cells in vitro to inhibit the production of immunoglobulins; it can inhibit the activity of purified cyclooxygenase-2 (COX-2) in vitro (IC50=7.7μg/ml), but has no effect on the activity of cyclooxygenase-1 (COX-1).
Registered Holders
-
Zhejiang Hengkang Pharmaceutical Co., Ltd.
Active
China
-
TianJin TaiPu Pharmaceutical Co., Ltd.
Active
China
-
CHEER FINE Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Iguratimod
-
CN
3 YRS
Business licensedTrader Supplier of Apigenin,PQQ,NMNHInquiryUnit Price: $5.15-6.18 /G FOBCAS No.: 123663-49-0Grade: Chemical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional SupplementsInquiryCAS No.: 123663-49-0Grade: Pharmaceutical GradeContent: 99.5% -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 123663-49-0Grade: Industrial GradeContent: 99% -
CN
4 YRS
Business licensedTrader Supplier of additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst,API -
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
Learn More Other Chemicals
-
2,4-Dichloro-3-methylpyridine
132097-09-7
-
2,6-Dibromo-3-fluoropyridine
41404-59-5
-
Triphenylacetic acid
595-91-5
-
3-Chloro-5-fluoro-4-pyridinecarboxylic acid Formula
514798-03-9
-
2-CHLORO-4-PHENYLPYRIDINE Formula
42260-39-9
-
2-Phenyl-4-quinolinecarboxylic acid Formula
132-60-5
-
(-)-Flurbiprofen Structure
51543-40-9
-
Naproxen sodium Structure
26159-34-2
-
What is Glycine, N,N-diethyl-, 4-(acetylamino)phenyl ester, hydrochloride (1:1)
66532-86-3
-
What is 2-[(3-Chlorophenyl)amino]benzoic acid
13278-36-9